Found 40 matching trials
Tarlatamab Treatment Before and After Surgery in Surgically Resectable Recurrent High-grade Glioma: a Window of Opportunity Study (TARLAGLIA Study) PHASE1 This is a single-arm, window-of-opportunity clinical study evaluating tarla...
Show More Location
Hospital Universitari Vall D Hebron
Learn More & Join Trial
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer PHASE3 The main objective is to compare the efficacy of tarlatamab with standard o...
Show More Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Learn More & Join Trial
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC) PHASE1 The primary objective of this study is to evaluate the safety and tolerabil...
Show More Status
Active Not Recruiting
Location
City of Hope Orange County Lennar Foundation Cancer Center
Learn More & Join Trial
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) PHASE3 The main objective of the study is to compare the efficacy of tarlatamab in...
Show More Location
Cancer and Blood Specialists of Arizona
Learn More & Join Trial
Tarlatamab in Recurrent Gynecological Neuroendocrine Carcinomas: A Phase II Proof-of-concept Study PHASE2 Neuroendocrine carcinoma of the cervix (NECC) is an aggressive histological...
Show More Location
Hôpitaux Universitaires de Strasbourg
Learn More & Join Trial
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients PHASE2 This is an open-label, phase II, exploratory and multi-centre clinical tria...
Show More Location
Hospital General Universitario de Albacete
Learn More & Join Trial
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) PHASE3 The primary objective of this study is to compare the efficacy of tarlatama...
Show More Status
Active Not Recruiting
Location
Valkyrie Clinical Trials
Learn More & Join Trial
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC) PHASE1 The primary objective of this trial is to evaluate the safety and tolerabil...
Show More Location
City of Hope Cancer Center Phoenix
Learn More & Join Trial
A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC PHASE2 The primary objective of this study is to describe the antitumor activity o...
Show More Status
Active Not Recruiting
Location
University of California Los Angeles
Learn More & Join Trial
SCLC Tarlatamab Blood Collection N/A The overall objective of this project is to prospectively collect blood sam...
Show More Location
Multiple Locations
Learn More & Join Trial